The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
COMPASS Pathways plc(NASDAQ:CMPS) 
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited a...
Website: https://compasspathways.com/
Founded: 2016
CEO: George Goldsmith
Sector: Other
Industry: Other
Share this website to your friends
COMPASS Pathways plc Days Payable Outstanding ttm (DPO)
COMPASS Pathways plc Days Receivable Outstanding ttm (DSO)
COMPASS Pathways plc Days Inventory Outstanding ttm (DIO)
COMPASS Pathways plc Op Cashflow Per Share ttm
COMPASS Pathways plc Free Cashflow Per Share ttm
COMPASS Pathways plc Cash Per Share ttm
COMPASS Pathways plc P/S ratio ttm
COMPASS Pathways plc (GAAP) P/E ratio ttm
COMPASS Pathways plc P/B ratio ttm
No extra charts and metrics for this ticker.